Challenging Cases of Severe COVID-19: Unlikely Patients and Breakthrough Infections
Program Overview
When we think of severe COVID-19 infection, we often do not think of the young and otherwise healthy. In this activity, an interprofessional panel of experts dive into discussion on some unlikely severe COVID-19 cases and breakthrough infections as submitted directly by clinicians from all over the country.
This activity is intended for emergency medicine, hospital medicine, infectious disease, internal medicine, and pediatric clinicians (MD/NP/PA/Nurses) involved in the treatment of patients with severe COVID-19 infection.
Educational Objectives
Upon completion of this activity, participants should be better able to:
Assess disease severity and implications in patients with COVID-19
Integrate the unique roles and responsibilities of interprofessional care team members in the management of severe COVID-19 in hospitalized patients
Activity Faculty
Julia B. García-Díaz, MD, MSc, FACP, FIDSA, CPI
Director, Clinical Infectious Diseases Research and MultiSpecialties Clinical Associate Professor, Medicine (Tulane University) Associate Professor, University of Queensland/Ochsner Clinical School, Brisbane, Australia
Ochsner Health
New Orleans, LA
Thomas F. Patterson, MD, FACP, FIDSA
Chief, Division of Infectious Diseases Vice-Chair, Faculty Development Professor, Medicine Director, San Antonio Center for Medical Mycology
UT Health San Antonio
San Antonio, TX
Fiona A. Winterbottom, DNP, MSN, APRN, ACNS-BC, ACHPN, CCRN
Advanced Practice Provider, Pulmonary Critical Care Chairperson, System Critical Care Integration Council
Ochsner Medical Center
Ochsner Health
New Orleans, LA